Work

Case Report: Retrospective pharmacist-led multidimensional assessment in a patient with late-onset first-episode mania and elevated creatine kinase

Year: 2026
Type: article
Study design: Case Report
Abstract: Background Late-onset first-episode mania (LOFEM) in adults aged ≥50 years is rare and frequently complicated by cerebrovascular lesions, multimorbidity, and polypharmacy, all of which increase the risk of adverse events such as rhabdomyolysis. Differentiating agitation-related from drug-induced creatine kinase (CK) elevation in this setting is clinically challenging but critical for safe pharmacotherapy. This retrospective, post-discharge pharmacist-led multidimensional assessment explored how etiological differentiation could be achieved. Case presentation A 60-year-old woman with no prior psychiatric history presented with first-episode mania. On day 2, after a single 50 mg dose of quetiapine and an intramuscular injection of diazepam on day 1 (baseline CK was not measured), her CK was 780.9 U/L and myoglobin 112.61 ng/mL, consistent with mild biochemical rhabdomyolysis without acute kidney injury. Quetiapine was continued and titrated to 200 mg/day, combined with valproate and modified electroconvulsive therapy. CK normalized by day 21 and the patient achieved full recovery of psychiatric symptoms. Conclusions A post-discharge, retrospective multidimensional pharmaceutical assessment (Naranjo scale, Beers criteria, multi-database drug-drug interaction analysis, and geriatric dose evaluation) indicated that the overall picture was most consistent with mild biochemical rhabdomyolysis related to manic agitation and dehydration/exertion, with intramuscular diazepam as an additional confounder. Quetiapine cannot be excluded as a contributor. NMS was not clinically supported.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236690541
FWCI:
Cites: 37
Cited by:
Related to: 10
Parts: 2